Hester Biosciences Ltd
NSE :HESTERBIO BSE :524669 Sector : PharmaceuticalsBuy, Sell or Hold HESTERBIO? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
23 Dec 2382.05 (0.44%) | 20 Dec 2371.65 (-1.43%) | 19 Dec 2406.05 (-0.96%) | 18 Dec 2429.35 (-0.32%) | 17 Dec 2437.05 (-0.51%) | 16 Dec 2449.60 (0.10%) | 13 Dec 2447.25 (2.44%) | 12 Dec 2388.85 (-1.74%) | 11 Dec 2431.20 (-1.93%) | 10 Dec 2479.15 (-1.63%) | 09 Dec 2520.35 (-1.22%) | 06 Dec 2551.35 (-1.78%) | 05 Dec 2597.55 (-0.06%) | 04 Dec 2599.15 (-0.65%) | 03 Dec 2616.05 (0.48%) | 02 Dec 2603.45 (0.26%) | 29 Nov 2596.80 (-0.12%) | 28 Nov 2599.80 (-0.53%) | 27 Nov 2613.55 (-2.16%) | 26 Nov 2671.20 (0.97%) | 25 Nov 2645.60 (10.91%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Neutral
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
2399
10 DMA
Bearish
2420.42
20 DMA
Bearish
2509.19
50 DMA
Bearish
2448.22
100 DMA
Bearish
2474.39
200 DMA
Bullish
2197.44
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Dec 23, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 2490.39 | 2465.12 | 2400.42 | - | - |
R2 | 2465.12 | 2439.6 | 2394.3 | 2461.05 | - |
R1 | 2423.59 | 2423.84 | 2388.17 | 2415.45 | 2444.35 |
P | 2398.32 | 2398.32 | 2398.32 | 2394.25 | 2408.7 |
S1 | 2356.79 | 2372.8 | 2375.93 | 2348.65 | 2377.55 |
S2 | 2331.52 | 2357.04 | 2369.8 | 2327.45 | - |
S3 | 2289.99 | 2331.52 | 2363.68 | - | - |
Key Metrics
EPS
37.23
P/E
64.22
P/B
6.25
Dividend Yield
0.25%
Market Cap
2,026 Cr.
Face Value
10
Book Value
382.47
ROE
7.41%
EBITDA Growth
20.96 Cr.
Debt/Equity
0.91
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Hester Biosciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 76.36 | 69.18 | 83.88 | 84.35 | 86.49 |
PROFIT | 4.09 | 3.98 | 4.95 | 6.34 | 8.2 |
EPS | 4.75 | 4.73 | 7.52 | 8.8 | 9.86 |
Hester Biosciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 67.65 | 66.49 | 74.08 | 74.52 | 74.85 |
PROFIT | 6.78 | 6.48 | 7.43 | 8.43 | 9.34 |
EPS | 7.97 | 7.61 | 8.74 | 9.91 | 10.97 |
Profit & Loss (Figures in Rs. Crores)
Hester Biosciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 87.16 | 104.74 | 120.21 | 145.15 | 192.89 | 205.81 | 215.41 | 259.73 | 290.9 | 311.06 | |
PROFIT | 11.6 | 19.37 | 23.62 | 25.59 | 41.61 | 28.8 | 36.62 | 39.23 | 26.62 | 18.87 | |
EPS | 15.1 | 21.71 | 26.79 | 27.12 | 47.84 | 36.44 | 40.79 | 46.41 | 32.96 | 24.88 |
Hester Biosciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 87.16 | 104.73 | 120.7 | 142.9 | 181.54 | 187.93 | 206.12 | 236.54 | 264.09 | 279.06 | |
PROFIT | 11.96 | 19.39 | 25.01 | 30.53 | 43.89 | 30.84 | 43.59 | 39.43 | 32.33 | 27.14 | |
EPS | 15.82 | 22.6 | 29.32 | 35.92 | 51.55 | 36.7 | 46.9 | 46.45 | 38.02 | 31.93 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserves Total | 283.29 | 271.22 | 251.48 | 219.8 | 192.57 | 168.95 | 132.13 | 113.44 | 93.2 | 76.41 |
Total Shareholders Funds | 291.8 | 279.73 | 259.99 | 228.31 | 201.08 | 177.46 | 140.64 | 121.95 | 101.71 | 84.92 |
Minority Interest | 11.08 | 8.82 | 7.41 | 7.65 | 5.42 | 3.7 | 4.37 | 4.6 | 4.65 | 2.87 |
Secured Loans | 239.04 | 268.15 | 222.57 | 104.52 | 120.68 | 79.85 | 63.52 | 56.21 | 58.91 | 54.21 |
Unsecured Loans | 5.34 | 6 | 5.6 | 5.5 | 0 | 10 | 5.26 | 10 | 0 | 0.9 |
Total Debt | 244.38 | 274.15 | 228.17 | 110.02 | 120.68 | 89.85 | 68.78 | 66.21 | 58.91 | 55.11 |
Other Liabilities | 59.17 | 34.9 | 21.55 | 18.42 | 11.35 | 0.62 | 0.05 | 0.15 | 0.15 | 0.75 |
Total Liabilities | 606.43 | 597.6 | 517.12 | 364.4 | 338.53 | 271.63 | 213.84 | 192.91 | 165.42 | 143.65 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 382.04 | 385.8 | 348.16 | 228.07 | 225.75 | 215.44 | 170.08 | 152.81 | 108.25 | 97.57 |
Less: Accumulated Depreciation | 141.93 | 126.43 | 110.99 | 95.36 | 83.5 | 70.84 | 60 | 50.33 | 43.62 | 37.97 |
Net Block | 240.11 | 259.37 | 237.17 | 132.71 | 142.25 | 144.6 | 110.08 | 102.48 | 64.63 | 59.6 |
Capital Work in Progress | 171.4 | 148.61 | 81.91 | 109.17 | 74.15 | 7.05 | 31.81 | 21.29 | 36.46 | 32.6 |
Investments | 29.93 | 25.31 | 21.24 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.28 |
Inventories | 75.58 | 84.81 | 75.38 | 62.22 | 63.97 | 50.79 | 39.76 | 33.41 | 33.62 | 29.11 |
Sundry Debtors | 78.65 | 79.63 | 55.28 | 49.21 | 58.44 | 32.87 | 32.29 | 26.53 | 26.24 | 17.76 |
Cash and Bank Balance | 15.3 | 14.82 | 25.2 | 21.27 | 23.53 | 41.05 | 13.39 | 11.48 | 5.28 | 6.58 |
Loans and Advances | 45.08 | 48.34 | 38.9 | 28.8 | 13.38 | 16.95 | 13.01 | 8.54 | 9.06 | 6.55 |
Total Current Assets | 214.61 | 227.6 | 194.77 | 161.5 | 159.31 | 141.66 | 98.45 | 79.97 | 74.2 | 60.01 |
Current Liabilities | 45.3 | 61.12 | 37.33 | 31.89 | 38.8 | 16.9 | 21.32 | 15.24 | 10.37 | 7.74 |
Provisions | 3.22 | 3.9 | 1.22 | 7.48 | 0.46 | 0.26 | 1.07 | 1.18 | 2.02 | 3.74 |
Total Current Liabilities & Provisions | 48.51 | 65.03 | 38.55 | 39.37 | 39.26 | 17.16 | 22.39 | 16.42 | 12.39 | 11.48 |
Net Current Assets | 166.1 | 162.57 | 156.22 | 122.13 | 120.05 | 124.49 | 76.06 | 63.55 | 61.81 | 48.52 |
Deferred Tax Assets | 1.22 | 1.01 | 0.75 | 0.35 | 0 | 0 | 2.28 | 5.26 | 0.03 | 0.06 |
Deferred Tax Liability | 8.63 | 8.36 | 7.26 | 7.63 | 8.82 | 10.66 | 10.1 | 8.81 | 8.06 | 5.39 |
Net Deferred Tax | -7.41 | -7.35 | -6.51 | -7.28 | -8.82 | -10.66 | -7.82 | -3.55 | -8.03 | -5.33 |
Other Assets | 6.29 | 9.09 | 27.08 | 7.67 | 10.9 | 6.14 | 3.7 | 9.14 | 10.47 | 7.97 |
Total Assets | 606.43 | 597.6 | 517.11 | 364.4 | 338.53 | 271.63 | 213.83 | 192.91 | 165.41 | 143.64 |
Contingent Liabilities | 0 | 0.2 | 0.15 | 0.15 | 0.11 | 0.11 | 0.67 | 0.62 | 0.62 | 0.56 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserves Total | 304.21 | 283.88 | 259.93 | 229.07 | 194.57 | 170.93 | 137.57 | 113.58 | 91.81 | 75.74 |
Total Shareholders Funds | 312.72 | 292.39 | 268.44 | 237.58 | 203.08 | 179.44 | 146.08 | 122.09 | 100.32 | 84.25 |
Secured Loans | 133.56 | 164.32 | 121.91 | 15.9 | 47.9 | 28.29 | 37.62 | 29.43 | 38.66 | 37.82 |
Unsecured Loans | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 10 | 0 | 0.9 |
Total Debt | 133.56 | 164.32 | 121.91 | 15.9 | 47.9 | 38.29 | 42.62 | 39.43 | 38.66 | 38.72 |
Other Liabilities | 52.96 | 26.42 | 1.63 | 0.3 | 0.15 | 0.05 | 0.05 | 0.15 | 0.15 | 0.54 |
Total Liabilities | 499.24 | 483.13 | 391.98 | 253.78 | 251.13 | 217.78 | 188.75 | 161.67 | 139.13 | 123.51 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 203.62 | 199 | 171.17 | 164.59 | 166.32 | 161.48 | 120.75 | 109.41 | 105.07 | 94.4 |
Less : Accumulated Depreciation | 100.16 | 90.78 | 86.86 | 77.95 | 69.85 | 60.88 | 54.15 | 48.7 | 43.5 | 37.87 |
Net Block | 103.46 | 108.22 | 84.31 | 86.64 | 96.47 | 100.6 | 66.6 | 60.71 | 61.57 | 56.53 |
Capital Work in Progress | 171.4 | 148.61 | 81.91 | 3.72 | 0.87 | 0.42 | 30.47 | 21.29 | 10.47 | 14.27 |
Investments | 64.69 | 64.69 | 64.69 | 43.89 | 40.67 | 28.22 | 14.48 | 8.6 | 8.67 | 8.88 |
Inventories | 68.53 | 79.22 | 70.73 | 57.01 | 60.43 | 48.5 | 38.7 | 33.07 | 33.62 | 29.11 |
Sundry Debtors | 85.78 | 82.36 | 56.92 | 45.55 | 44.76 | 32.67 | 31.94 | 26.71 | 26.24 | 17.76 |
Cash and Bank Balance | 4.96 | 5.96 | 1.98 | 1.24 | 5.19 | 2.49 | 11.95 | 11.48 | 5.26 | 4.38 |
Loans and Advances | 45.15 | 48.51 | 36.84 | 35.8 | 12.8 | 15.74 | 6.54 | 3.56 | 2.07 | 1.51 |
Total Current Assets | 204.42 | 216.05 | 166.47 | 139.61 | 123.18 | 99.4 | 89.13 | 74.82 | 67.19 | 52.77 |
Current Liabilities | 40.55 | 51.71 | 25 | 17.62 | 17.33 | 12.11 | 13.36 | 12.04 | 9.65 | 7.64 |
Provisions | 2.67 | 3.83 | 1.18 | 3.81 | 0.44 | 0.26 | 1.06 | 1.18 | 2.02 | 3.95 |
Total Current Liabilities & Provisions | 43.22 | 55.54 | 26.18 | 21.42 | 17.77 | 12.37 | 14.41 | 13.22 | 11.67 | 11.58 |
Net Current Assets | 161.19 | 160.51 | 140.3 | 118.19 | 105.41 | 87.03 | 74.72 | 61.59 | 55.52 | 41.18 |
Deferred Tax Assets | 0.96 | 0.72 | 0.46 | 0.31 | 0 | 0 | 2.18 | 5.26 | 0.03 | 0.06 |
Deferred Tax Liability | 8.05 | 7.87 | 6.75 | 7.12 | 8.29 | 10.09 | 9.51 | 8.81 | 8.06 | 5.39 |
Net Deferred Tax | -7.09 | -7.15 | -6.29 | -6.81 | -8.29 | -10.09 | -7.33 | -3.55 | -8.03 | -5.33 |
Other Assets | 5.59 | 8.25 | 27.06 | 8.17 | 15.99 | 11.61 | 9.81 | 13.02 | 10.93 | 7.97 |
Total Assets | 499.24 | 483.12 | 391.98 | 253.8 | 251.13 | 217.78 | 188.75 | 161.66 | 139.13 | 123.5 |
Contingent Liabilities | 116.77 | 115.24 | 106.45 | 103.05 | 208.44 | 27.78 | 0.67 | 0.62 | 0.62 | 0.56 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 31.95 |
Depreciation | 17.17 |
Interest (Net) | 17.56 |
P/L on Sales of Assets | -0.03 |
Prov. and W/O (Net) | 0.71 |
P/L in Forex | -0.12 |
Fin. Lease and Rental Charges | -1.18 |
Others | 26 |
Total Adjustments (PBT and Ext... | 24.22 |
Operating Profit before Workin... | 56.18 |
Trade and 0ther Receivables | 0.4 |
Inventories | 9.23 |
Trade Payables | -3.54 |
Loans and Advances | 0.13 |
Total Adjustments (OP before W... | 3.63 |
Cash Generated from/(used in) ... | 59.8 |
Direct Taxes Paid | -11.67 |
Total Adjustments(Cash Generat... | -11.67 |
Cash Flow before Extraordinary... | 48.13 |
Net Cash from Operating Activi... | 48.13 |
Sale of Fixed Assets | 0.06 |
Interest Received | 1.89 |
Net Cash used in Investing Act... | -22.5 |
Proceed from 0ther Long Term B... | 20.47 |
Of the Long Tem Borrowings | -22.97 |
Of the Short Term Borrowings | -27.51 |
Of Financial Liabilities | -0.3 |
Dividend Paid | -6.81 |
Interest Paid | -14.94 |
Net Cash used in Financing Act... | -26.05 |
Net Profit before Tax and Extr... | 36.73 |
Depreciation | 9.78 |
Interest (Net) | 2.98 |
P/L on Sales of Assets | -0.03 |
Prov. and W/O (Net) | 0.71 |
P/L in Forex | -0.12 |
Others | 26 |
Total Adjustments (PBT and Ext... | 13.32 |
Operating Profit before Workin... | 50.06 |
Trade and 0ther Receivables | -4.01 |
Inventories | 10.69 |
Trade Payables | 1.41 |
Loans and Advances | 0.16 |
Total Adjustments (OP before W... | 3.79 |
Cash Generated from/(used in) ... | 53.84 |
Direct Taxes Paid | -11.03 |
Total Adjustments(Cash Generat... | -11.03 |
Cash Flow before Extraordinary... | 42.81 |
Net Cash from Operating Activi... | 42.81 |
Sale of Fixed Assets | 0.06 |
Interest Received | 1.89 |
Net Cash used in Investing Act... | -20.63 |
Proceed from 0ther Long Term B... | 20.2 |
Of the Long Tem Borrowings | -22.82 |
Of the Short Term Borrowings | -27.55 |
Dividend Paid | -6.81 |
Interest Paid | -13.1 |
Net Cash used in Financing Act... | -24.07 |
Company Details
Registered Office |
|
Address | 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380006 |
Tel. No. | 91-079-26445107 |
Fax. No. | 91-079-26445105 |
investor@hesterbiosciences.co.in | |
Internet | http://www.hester.in |
Registrars |
|
Address | 1st Flr PushpakPachvati Circle |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380006 |
Tel. No. | 91-079-26445107 |
Fax. No. | 91-079-26445105 |
investor@hesterbiosciences.co.in | |
Internet | http://www.hester.in |
Management |
|
Name | Designation |
Bhupendra V Gandhi | Chairman (Non-Executive) |
Sanjiv D Gandhi | Non Executive Director |
Nina Gandhi | Alternate Director |
Sandhya Patel | Independent Director |
Ashok Bhadakal | Independent Director |
Ameet Desai | Independent Director |
Rajiv D Gandhi | Managing Director & CEO |
Ravin Gandhi | Non Executive Director |
PRIYA RAJIV GANDHI | Executive Director |
Anil Jain | Independent Director |
Jatin Yagneshbhai Trivedi | Independent Director |